HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome
<h2>Purpose</h2> <p>Apocrine carcinoma of the breast (APO) expresses HER2 in 30–50% of cases. This study explored the clinicopathological features and outcome of HER2+/APO and matched HER2+/NST cohort.</p> <h2>Methods</h2> <p>We used the SEER database to exp...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|